Equity Capital: 329.63 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 6,206.94 | 33,704.16 |
LAST 3M | 18,301.56 | 58,999.00 |
LAST 6M | 64,412.59 | 43,706.77 |
LAST 12M | 118,019.00 | 92,784.99 |
Date | Action Type | Ratio |
---|---|---|
Jul 26, 2022 | Dividend | 100 |
Aug 12, 2021 | Dividend | 60 |
TTK Healthcare, a TTK group company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov `81. Some of the other companies belonging to the TTK group include London Rubber, TT Textiles, TTK Chemicals, etc. The company concentrate on pharmaceutical, consumer products and hospital care products. The company is the owner of famous Woodwards Gripewater brand. In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion. Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc. It also has a consumer products and food division manufacturing kiwi shoe polishes, snacks, etc. The company has collaborations with a number of foreign corporations such as London International, Kali-Chemi, Germany; Hatu-ICO, Spain; Nicholas Kiwi, US, etc. The products of the company are exported to the UK, Egypt, the US, Germany, Singapore, Malaysia, Carribean countries, etc. The Pallavaram plant of the company has been accredited with the ISO 14002 certification by the Bureau of Indian Standards. Also, one of the group companies, TT Maps and Publications was merged with TTK Pharma in 1993. The company faced some rough weather in Jul.`95 when the MRTPC ordered an inquiry against it for allegedly directing its whole-salers to keep a minimum stock of the company`s products and defining their area of operations. During 1996-97, the company has tied up with M/s Mentholatum India Pvt Ltd. During the year 1999-2000, as a part of the restructuring programme, the paper divison of the company has been disposed off and the merger of TTK Biomed has been approved by the Hon`ble High Court Of Madras with retrospective effect from July 1, 1999. In 2000-01, the company has vacated the bulk drug business segment by disposing of the Bulk Drugs & Formulations facility at Hyderabad. The High Court, Madras has approved the scheme of amlagamation between TTK Medical Devices Ltd. and the company. During the financial year 2003-04,the Heart Valve division of the company has been awarded ISO 9001-2000 Certification by RWTUV,Germany.
6 Cathedral Road, , Chennai, Tamil Nadu, 600086
Tel | : | 91-44-28116106-28116110 |
: | info:ttkhealthcare.com | |
Website | : | http://www.ttkhealthcare.com |
Data Software Research Co Ltd
AGM Date (Month) | : | Aug |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 507747 |
NSE Code | : | TTKHLTCARE |
Book Closure Date (Month) | : | |
BSE Group | : | B |
ISIN | : | INE910C01018 |
You can buy TTK Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy TTK Healthcare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 07, 2023 03:58 PM the closing price of TTK Healthcare Ltd was ₹ 1,259.85.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 07, 2023 03:58 PM, the market cap of TTK Healthcare Ltd stood at ₹ 1,780.17.
The latest PE ratio of TTK Healthcare Ltd as of Jun 07, 2023 03:58 PM is 39.76
The latest PB ratio of TTK Healthcare Ltd as of Jun 07, 2023 03:58 PM is 0.53
The 52-week high of TTK Healthcare Ltd is ₹ 1,474.00 while the 52-week low is ₹ 667.00